Dr. Shindiapina is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-4812
Education & Training
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2012 - 2015
- Geisel School of Medicine at DartmouthClass of 2012
- Ohio State University HospitalFellowship, Hematology and Medical Oncology
Certifications & Licensure
- OH State Medical License 2015 - 2026
- NH State Medical License 2012 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- PRMT5 Inhibition Reduces Hyperinflammation in a Murine Model of Secondary Hemophagocytic Lymphohistiocytosis (HLH).Fiona Brown-Burke, Rachel Saadey, Hsiao-Yin Charlene Charlene Mao, Paola Marra, Eric Brooks
Blood Advances. 2025-01-18 - Single-center study of outcomes of patients with hairy cell leukemia who contracted SARS-CoV-2.Kaitlin Annunzio, Michael Ozga, Ying Huang, Mirela Anghelina, Seema A Bhat
Ejhaem. 2023-11-01 - 2 citationsFollicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein-Barr Virus Lymphoproliferative Disorder.Elshafa Hassan Ahmed, Mark Lustberg, Claire Hale, Shelby Sloan, Charlene Mao
Cancers. 2023-06-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: